Abstract:The formulation and characterization of novel cardiovascular supplements and drugs without any side effects are in both developed and developing countries research priority. Myocardial ischemia-reperfusion causes to an inflammatory response that leads more damage to apoptosis. Chronic and acute immune responses elicited by myocardial ischemia is in the heart functional deterioration. In this study, we formulated a modern cardioprotective protective drug by gold nanoparticles containing Silybum marianum on isoproterenol-induced myocardial ischemia mice by investigating the PPAR-gamma/NF-kappa B pathway. Determining the antioxidant capacities of gold nanoparticles was done with the conventional free radical scavenging test, i.e., DPPH in the presence of butylated hydroxytoluene as the positive control. The gold nanoparticles were characterized by standard physicochemical techniques, including FT-IR, FE-SEM, UV-Vis, and TEM. The nanoparticles inhibited half of the DPPH molecules in the concentration of 72 mu g/mL. In the in vivo design, to induce myocardial ischemia in C57BL/6 mice, isoproterenol (40 mg/kg) was administered. The mice were randomly divided into five groups: (1) control; (2) isoproterenol; (3-5) isoproterenol + gold nanoparticles at different doses (10, 20 and 40 mu g/ml) and timings. After treatment, cardiac function was evaluated by histochemical and biochemical analysis. Gold nanoparticles treatment decreased the inflammatory milieu in the myocardial ischemia mice heart, thereby blocking the proinflammatory cytokines upregulation (IL-1 ss, TNF-alpha and IL-6). Also, gold nanoparticles treatment significantly ameliorate ventricular wall ischemia, reduces the mortality incidence, and inhibits the myocardial injury markers levels. In addition, gold nanoparticles administration significantly prevents the typical ST segment depression. Treatment with gold nanoparticles significantly suppresses the inflammation cytokines expression and decrease cell death. The gold nanoparticles beneficial effects is related to the normalization in PPAR-gamma and PPAR-gamma/NF-kappa B/I kappa B-alpha/IKK alpha/ss phosphorylation gene expression. Gold nanoparticles exert cardioprotective properties against isoproterenol-induced myocardial ischemia in mice, which may associated to the PPAR-gamma activation and NF-kappa B signaling inhibition.

RGD Modified and PEGylated Lipid Nanoparticles Loaded with Puerarin: Formulation, Characterization and Protective Effects on Acute Myocardial Ischemia Model.

[In vitro evaluation, cellular uptake and anti-acute myocardial ischemia effect of puerarin PEG-PLGA micelles]

Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats

Puerarin-Loaded Liposomes Co-Modified by Ischemic Myocardium-Targeting Peptide and Triphenylphosphonium Cations Ameliorate Myocardial Ischemia-Reperfusion Injury

αvβ3 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia

PEG-modified nano liposomes co-deliver Apigenin and RAGE-siRNA to protect myocardial ischemia injury

Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury

Cardiac-targeted and ROS-responsive liposomes containing puerarin for attenuating myocardial ischemia-reperfusion injury

PLGA nanoparticles enhanced cardio-protection of scutellarin and paeoniflorin against isoproterenol-induced myocardial ischemia in rats

Protective Properties of Nanoparticles Green-Synthesized by Plant on Myocardial Ischemia

Enhanced protection against hypoxia/reoxygenation-induced apoptosis in H9c2 cells by puerarin-loaded liposomes modified with matrix metalloproteinases-targeting peptide and triphenylphosphonium

Enhanced treatment for cerebral ischemia-reperfusion injury of puerarin loading liposomes through neutrophils-mediated targeted delivery

ROS-triggered drug release of puerarin from boronic ester modified nanoparticles to reduce oxidative damage in HUVECs

Retraction Note: Cardioprotective Activity of Placental Growth Factor in a Rat Model of Acute Myocardial Infarction: Nanoparticle-Based Delivery Versus Direct Myocardial Injection

Targeted delivery of puerarin/glycyrrhetinic acid-PEG-PBLA complex attenuated liver ischemia/reperfusion injury via modulating Toll-like receptor 4/nuclear factor-κB pathway

Pharmacological Signatures of the Exenatide Nanoparticles Complex Against Myocardial Ischemia Reperfusion Injury

Formulation and Pharmacokinetics Evaluation of Puerarin Nanocrystals for Intravenous Delivery

Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound

[Pharmacokinetics, pharmacodynamics, and tissue distribution of oral co-loaded puerarin/daidzein mixed micelles in rats]

Enhanced Oral Bioavailability of Acetylpuerarin by Poly(lactide-Co-glycolide) Nanoparticles Optimized Using Uniform Design Combined with Response Surface Methodology

An enhanced cardio-protective effect of nanoparticles loaded with active components from Polygonum orientale L. against isoproterenol-induced myocardial ischemia in rats